Tom Lent | July 10, 2018
The Healthy Building Network (HBN) has rolled out a new tool for identifying chemicals of concern and finding less hazardous alternatives. The Chemical Hazard Data Commons combines the power of HBN’s Pharos Chemical and Material Library with new tools for visualizing hazard scoring, comparing hazards for chemical lists, staying on top of changes, finding safer alternatives, surveying other databases, and tapping the wisdom of the Data Commons community to collaborate on problem solving and solutions.
Complete Hazard Profiles
The Data Commons provides a detailed profile of each of over 85,000 substances, with single-page access to:
Powerful search: A catalog of over 260,000 chemical names, trade names, CAS registry numbers, and other synonyms combines with a smart search tool that can work with spelling variations to help you find the substance you seek.
Chemical comparisons & hazard updates: Upload a spreadsheet of chemicals into the Data Commons Comparison tool and instantly generate a matrix comparing the health endpoints and the GreenScreen scores for each chemical. Subscribe to be notified when the hazards change as the science evolves and listings are revised.
Portal to a world of data: Need to learn more? The Data Commons does the search for you providing one-click access to your target chemical’s record in up to 12 other External Resource databases, such as PubChem, PubMed, TRI, and REACH registration dossiers.
Collaborate: The Data Commons hosts a wide range of discussions between researchers, practitioners, advocates, manufacturers, and government agency staff tackling the challenges of hazard assessment. These have recently ranged from challenges with the Six Classes concept, to identifying hazardous chemicals in plastic packaging, to parsing out different names for phthalates.
After extensive testing by hundreds of users, the Data Commons is now available and free to the public. Try the Chemical Hazard Data Commons today.
The Chemical Hazard Data Commons is made possible by the generous support of the Forsythia Foundation, the Lisa & Douglas Goldman Fund, and the John Merck Fund.